The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Basic local alignment search tool

Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

Wiedenmann, B. J., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,432

Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation

Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361

Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases

Kennelly, P. J., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98436-x · Cited by 1,331

Exocytosis and Spreading of Normal and Aberrant α‐Synuclein

Emmanouilidou, E., & Vekrellis, K. (2016) · Brain Pathology · doi:10.1111/bpa.12373 · Cited by 71

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, D., Rodriguez-Vieitez, E., Sando, S. B., Berge, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., Patra, K., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0624-z · Cited by 68

Conformational templating of α-synuclein aggregates in neuronal-glial cultures

Sacino, A. N., Thomas, M. A., Ceballos‐Diaz, C., Cruz, P. E., Rosario, A. M., Lewis, J. M., Giasson, B. I., & Golde, T. E. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-17 · Cited by 68

Disorders of synaptic vesicle fusion machinery

Melland, H., Arvell, E. H., & Gordon, S. L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15181 · Cited by 66

Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease

Luna, E., & Luk, K. C. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.023 · Cited by 67

α-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles

Varkey, J., Mizuno, N., Hegde, B. G., Cheng, N., Steven, A. C., & Langen, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476697 · Cited by 71

AMPA‐receptor‐mediated excitatory synaptic transmission is enhanced by iron‐induced α‐synuclein oligomers

Hüls, S., Högen, T., Vassallo, N., Danzer, K., Hengerer, B., Giese, A., & Herms, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07254.x · Cited by 73

Expression of concern: Overexpression of synuclein‐γ in pancreatic adenocarcinoma

Li, Z., Sclabas, G. M., Peng, B., Hess, K. R., Abbruzzese, J. L., Evans, D. B., & Chiao, P. J. (2004) · Cancer · doi:10.1002/cncr.20321 · Cited by 66

Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders

Masliah, E. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3117 · Cited by 67

The chaperonin CCT inhibits assembly of α-synuclein amyloid fibrils by a specific, conformation-dependent interaction

Sot, B., Rubio-Muñoz, A., Leal-Quintero, A., Martínez-Sabando, J., Marcilla, M., Roodveldt, C., & Valpuesta, J. (2017) · Scientific Reports · doi:10.1038/srep40859 · Cited by 66

A dual role for α-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo

Somayaji, M., Cataldi, S., Choi, S. J., Edwards, R. H., Mosharov, E. V., & Sulzer, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013652117 · Cited by 67

The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain

Totterdell, S., Hanger, D. P., & Meredith, G. E. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.072 · Cited by 67

Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine

Kholodilov, N. G., Oo, T. F., & Burke, R. E. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00740-5 · Cited by 65

Intrinsically disordered proteins may escape unwanted interactions via functional misfolding

Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.03.010 · Cited by 68

Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications

Ottolini, D., Calí, T., Szabó, I., & Brini, M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0201 · Cited by 65

α-Synuclein: Its Biological Function and Role in Neurodegenerative Diseases

Kaplan, B., Ratner, V., & Haas, E. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:83 · Cited by 64

Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease

Iseki, E., Marui, W., Kosaka, K., & Uéda, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00178-0 · Cited by 65

Caenorhabditis elegans as a model system for studying aging-associated neurodegenerative diseases

Pelt, K. M. V., & Truttmann, M. C. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.05.001 · Cited by 62

The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders

Torres, C. A. M., Wassouf, Z., Zafar, F., Sastre, D., Outeiro, T. F., & Schüle, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165724 · Cited by 64

α-Synuclein Aggregates Interfere with Parkin Solubility and Distribution

Kawahara, K., Hashimoto, M., Bar‐On, P., Ho, G. J., Crews, L. A., Mizuno, H., Rockenstein, E. M., Imam, S. Z., & Masliah, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710418200 · Cited by 64

Impact of Tyr to Ala mutations on α-synuclein fibrillation and structural properties

Ulrih, N. P., Barry, C. H., & Fink, A. L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.004 · Cited by 63

Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

Coskuner‐Weber, O., & Uversky, V. N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020336 · Cited by 71

Molecular Role of Ca2+ and Hard Divalent Metal Cations on Accelerated Fibrillation and Interfibrillar Aggregation of α-Synuclein

Han, J. Y., Choi, T. S., & Kim, H. I. (2018) · Scientific Reports · doi:10.1038/s41598-018-20320-5 · Cited by 64

Muscarinic Receptor Stimulation Induces Translocation of an α-Synuclein Oligomer from Plasma Membrane to a Light Vesicle Fraction in Cytoplasm

Leng, Y., Chase, T. N., & Bennett, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011121200 · Cited by 64

Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology

Wakabayashi, K., Fukushima, T., Koide, R., Horikawa, Y., Hasegawa, M., Watanabe, Y., Noda, T., Eguchi, I., Morita, T., Yoshimoto, M., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010050049 · Cited by 64

Interactions between fatty acids and α-synuclein

Luäcke, C., Gantz, D., Klimtchuk, E. S., & Hamilton, J. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600003-jlr200 · Cited by 64

Complex Seizure Disorder Caused by Brunol4 Deficiency in Mice

Yang, Y. X., Mahaffey, C. L., Bérubé, N. G., Maddatu, T. P., Cox, G. A., & Frankel, W. N. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030124 · Cited by 64

The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease

Gao, Y., Wilson, G. R. A., Stephenson, S. E. M., Bozaoglu, K., Farrer, M. J., & Lockhart, P. J. (2018) · Movement Disorders · doi:10.1002/mds.27270 · Cited by 65

Inhibitors of α-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson’s disease and related disorders

Amer, D. A. M., Irvine, G. B., & El‐Agnaf, O. M. A. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0539-y · Cited by 62

Role of Oxidative Damage in Protein Aggregation Associated with Parkinson's Disease and Related Disorders

Norris, E. H., & Giasson, B. I. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.672 · Cited by 61

Self-Assembly of Protein Fibrils into Suprafibrillar Aggregates: Bridging the Nano- and Mesoscale

Semerdzhiev, S. A., Dekker, D. R., Subramaniam, V., & Claessens, M. M. A. E. (2014) · ACS Nano · doi:10.1021/nn406309c · Cited by 62

Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein

Iljina, M., Tosatto, L., Choi, M. L., Sang, J. C., Ye, Y., Hughes, C. D., Bryant, C. E., Gandhi, S., & Klenerman, D. (2016) · Scientific Reports · doi:10.1038/srep33928 · Cited by 63

Coordination and redox properties of copper interaction with α-synuclein

Valensin, D., Dell’Acqua, S., Kozłowski, H., & Casella, L. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.012 · Cited by 61

Widespread occurrence of α‐synuclein/NACP‐immunoreactive neuronal inclusions in juvenileand adult‐onset Hallervorden–Spatz diseasewith Lewy bodies

Wakabayashi, Yoshimoto, Fukushima, Koide, R., Horikawa, Morita, & Takahashi, Y. (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00193.x · Cited by 61

More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy

Flores‐León, M., & Outeiro, T. F. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02601-0 · Cited by 62

Cell-to-Cell Transmission of α-Synuclein Aggregates

Lee, S., Desplats, P., Lee, H.-J., Spencer, B. J., & Masliah, E. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_23 · Cited by 61

Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements

Ruf, V., Nübling, G., Willikens, S., Shi, S., Schmidt, F., Levin, J., Bötzel, K., Kamp, F., & Giese, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00579 · Cited by 60

Gamma synuclein: Subcellular localization in neuronal and non‐neuronal cells and effect on signal transduction

Surguchov, A. P., Palazzo, R. E., & Surgucheva, I. G. (2001) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.1035 · Cited by 60

Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease

Iseki, E., Marui, W., Kosaka, K., Akiyama, H., Uéda, K., & Iwatsubo, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00856-8 · Cited by 60

α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

Alzghool, O. M., van Dongen, G. A. M. S., van de Giessen, E., Schoonmade, L. J., & Beaino, W. (2022) · Movement Disorders · doi:10.1002/mds.28984 · Cited by 62

Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins

Carnazza, K. E., Komer, L. E., Xie, Y. X., Pineda, A., Briano, J. A., Gao, V., Na, Y., Ramlall, T. F., Buchman, V. L., Eliezer, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110675 · Cited by 65

Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?

Plowey, E. D., & Chu, C. T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.011 · Cited by 62

Anti-aggregation and fibril-destabilizing effects of sex hormones on α-synuclein fibrils in vitro

Hirohata, M., Ono, K., Morinaga, A., Ikeda, T., & Yamada, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.003 · Cited by 60

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease

Mori, A., Imai, Y., & Hattori, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093301 · Cited by 60

Pathological Proteins in Parkinson's Disease: Focus on the Proteasome

Snyder, H. M., & Wolozin, B. L. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:425 · Cited by 62

Distribution of α‐ and γ‐synucleins in the adult rat brain and their modification by high‐dose cocaine treatment

Verca, M. S. B., Bahí, A., Boyer, F., Wagner, G. C., & Dreyer, J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02913.x · Cited by 59

Mechanisms of Alpha-Synuclein Action on Neurotransmission: Cell-Autonomous and Non-Cell Autonomous Role

Emanuele, M., & Chieregatti, E. (2015) · Biomolecules · doi:10.3390/biom5020865 · Cited by 60

Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism

Uversky, V. N. (2017) · F1000Research · doi:10.12688/f1000research.10536.1 · Cited by 59

α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?

Filippini, A., Gennarelli, M., & Russo, I. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00649-9 · Cited by 61

In-Cell Double Electron–Electron Resonance at Nanomolar Protein Concentrations

Kucher, S., Elsner, C., Safonova, M., Maffini, S., & Bordignon, E. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00048 · Cited by 57

Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human α-Synuclein

Zhou, W., Milder, J. B., & Freed, C. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710232200 · Cited by 57

Single Fibril Growth Kinetics of α-Synuclein

Wördehoff, M. M., Bannach, O., Shaykhalishahi, H., Kulawik, A., Schiefer, S., Willbold, D., Hoyer, W., & Birkmann, E. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.01.020 · Cited by 56

α-Synuclein Tertiary Contact Dynamics

Lee, J. C., Lai, B. T., Kozak, J. J., Gray, H. B., & Winkler, J. R. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp068604y · Cited by 57

The Membrane Interaction of Alpha-Synuclein

Liu, C., Zhao, Y., Xi, H., Jiang, J., Yu, Y., & Dong, W. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.633727 · Cited by 57

Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression

McLean, J. R., Hallett, P. J., Cooper, O., Stanley, M., & Ole Isacson, A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.11.006 · Cited by 63

Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution

Li, X., Dong, C., Hoffmann, M., Garen, C. R., Cortez, L. M., Petersen, N. O., & Woodside, M. T. (2019) · Scientific Reports · doi:10.1038/s41598-018-37584-6 · Cited by 57

Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease

Gilmozzi, V., Gentile, G., Rueda, M. P. C., Hicks, A. A., Pramstaller, P. P., Zanon, A., Lévesque, M., & Pichler, I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.578993 · Cited by 59

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes

Indrieri, A., Pizzarelli, R., Franco, B., & Leonibus, E. D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.567129 · Cited by 57

Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease

Beyer, K., Humbert, J., Ferrer, A. L., Lao, J. I., Carrato, C., López, D., Ferrer, I., & Ariza, A. (2006) · Neuroreport · doi:10.1097/01.wnr.0000224773.66904.e7 · Cited by 55

Upregulation of α‐synuclein by lipopolysaccharide and interleukin‐1 in human macrophages

Tanji, K., Mori, F., Imaizumi, T., Yoshida, H., Matsumiya, T., Tamo, W., Yoshimoto, M., Odagiri, H., Sasaki, M., Takahashi, H., et al. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01385.x · Cited by 55

An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease

Uchihara, T. (2016) · Neuropathology · doi:10.1111/neup.12348 · Cited by 55

Characterization of the human α-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms

Xia, Y., Saitoh, T., Uéda, K., Tanaka, S., Chen, X., Hashimoto, M., Hsu, L. J., Conrad, C., Sundsmo, M. P., Yoshimoto, M., et al. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3508 · Cited by 55

Familial Parkinson Disease-associated Mutations Alter the Site-specific Microenvironment and Dynamics of α-Synuclein

Sahay, S., Ghosh, D., Dwivedi, S., Arunagiri, A., Mohite, G. M., Kombrabail, M. H., Krishnamoorthy, G., & Maji, S. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598607 · Cited by 55

α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells

Bisaglia, M., Greggio, E., Maric, D., Miller, D. W., Cookson, M., & Bubacco, L. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-41 · Cited by 57

Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation

Oueslati, A., Ximerakis, M., & Vekrellis, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.324 · Cited by 58

Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy

Hu, Q., Ren, X., Liu, Y., Li, Z., Zhang, L., Chen, X., He, C., & Chen, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.040 · Cited by 56

Serum α-synuclein and IL-1β are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers?

Choi, J., Kim, S. Y., Kim, H., Lim, B. C., Hwang, H. Y., Chae, J., Kim, K. J., Oh, S., Kim, E. Y., & Shin, J. (2020) · BMC Neurology · doi:10.1186/s12883-020-01662-y · Cited by 55

The structural heterogeneity of α-synuclein is governed by several distinct subpopulations with interconversion times slower than milliseconds

Chen, J., Zaer, S., Drori, P., Zamel, J., Joron, K., Kalisman, N., Lerner, E., & Dokholyan, N. V. (2021) · Structure · doi:10.1016/j.str.2021.05.002 · Cited by 55

Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro

Hirohata, M., Ono, K., Morinaga, A., & Yamada, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.11.010 · Cited by 55

α-Synuclein Levels Are Elevated in Cerebrospinal Fluid following Traumatic Brain Injury in Infants and Children: The Effect of Therapeutic Hypothermia

Su, E. R., Bell, M. J., Wisniewski, S. R., Adelson, P. D., Janesko‐Feldman, K. L., Salonia, R., Clark, R. S. B., Kochanek, P. M., Kagan, V. E., & Bayır, H. (2010) · Developmental Neuroscience · doi:10.1159/000321342 · Cited by 55

Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain Injury

Barker, S., Paul, B., & Pieper, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041154 · Cited by 55

Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases

Pratt, M. R., & Vocadlo, D. J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105411 · Cited by 56

Conformational heterogeneity of α -synuclein in membrane

Vermaas, J. V., & Tajkhorshid, E. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.08.012 · Cited by 53

Accumulation of α-Synuclein Triggered by Presynaptic Dysfunction

Nakata, Y., Yasuda, T., Fukaya, M., Yamamori, S., Itakura, M., Nihira, T., Hayakawa, H., Kawanami, A., Kataoka, M., Nagai, M., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2220-12.2012 · Cited by 55

Localization of Alpha-synuclein to identified fibers and synapses in the normal mouse brain

Totterdell, S., & Meredith, G. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.047 · Cited by 53

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization

Dominguez‐Meijide, A., Vasili, E., König, A., Cima‐Omori, M., de Opakua, A. I., Leonov, A., Ryazanov, S., Zweckstetter, M., Griesinger, C., & Outeiro, T. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-69744-y · Cited by 52

α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils

Dearborn, A. D., Wall, J. S., Cheng, N., Heymann, J. B., Kajava, A. V., Varkey, J., Langen, R., & Steven, A. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698787 · Cited by 53

The Role of α-Synuclein in SNARE-mediated Synaptic Vesicle Fusion

Yoo, G., Shin, Y., & Lee, N. K. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167775 · Cited by 57

Brain Aβ amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau

Tomidokoro, Y., Harigaya, Y., Matsubara, E., Ikeda, M., Kawarabayashi, T., Shirao, T., Ishiguro, K., Okamoto, K., Younkin, S. G., & Shoji, M. (2001) · The Journal of Pathology · doi:10.1002/path.897 · Cited by 54

The Membrane Interactions of Synuclein: Physiology and Pathology

Runwal, G., & Edwards, R. H. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-031920-092547 · Cited by 57

Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases

Hassanzadeh, K., Liu, J., Maddila, S. C., & Mouradian, M. M. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001111 · Cited by 56

Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice

Inden, M., Kitamura, Y., Tamaki, A., Yanagida, T., Shibaike, T., Yamamoto, A., Takata, K., Yasui, H., Taira, T., Ariga, H., et al. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.07.009 · Cited by 52

Therapeutic approaches in Parkinson's disease and related disorders

Valera, E., & Masliah, E. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13529 · Cited by 53

Mechanism of Anti-α-Synuclein Immunotherapy

Lee, J. S., & Lee, S. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.15059 · Cited by 53

Neurons and Glia Interplay in α-Synucleinopathies

Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 55

A Novel Mechanism of Interaction between α-Synuclein and Biological Membranes

Kim, Y. S., Laurine, E., Woods, W. S., & Lee, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.05.004 · Cited by 54

Prominent Perikaryal Expression of α- and β-Synuclein in Neurons of Dorsal Root Ganglion and in Medullary Neurons

Giasson, B. I., Duda, J. E., Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7805 · Cited by 52

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease

Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor

Miller, K. M., Mercado, N. M., & Sortwell, C. E. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00179-6 · Cited by 54

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease

Magistrelli, L., Contaldi, E., & Comi, C. (2021) · Life · doi:10.3390/life11080804 · Cited by 63

Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy

Choi, I., Heaton, G. R., Lee, Y.-K., & Yue, Z. (2022) · Science Advances · doi:10.1126/sciadv.abn1298 · Cited by 54

Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway

Yuan, Y., Jin, J., Yang, B., Zhang, W., Hu, J., Zhang, Y., & Chen, N. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9185-6 · Cited by 50

Novel subcellular localization for α-synuclein: possible functional consequences

Guardia-Laguarta, C., Area-Gomez, E., Schon, E. A., & Przedborski, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00017 · Cited by 44

Interactions between metals and α‐synuclein − function or artefact?

Brown, D. R. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05917.x · Cited by 54

Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies

Vivacqua, G., Casini, A., Vaccaro, R., Fornai, F., Yu, S., & D’Este, L. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.12.003 · Cited by 51

Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides

Forloni, G., Tagliavini, F., Bugiani, O., & Salmona, M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00013-5 · Cited by 51

Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core

Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 51

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease

Kulkarni, A. S., Burns, M. R., Brundin, P., & Wesson, D. W. (2022) · Brain Communications · doi:10.1093/braincomms/fcac165 · Cited by 48

α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease

Braithwaite, S. P., Stock, J. B., & Mouradian, M. M. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2011-0067 · Cited by 50

Molecular Details of α-Synuclein Membrane Association Revealed by Neutrons and Photons

Jiang, Z., Hess, S. K., Heinrich, F., & Lee, J. C. (2015) · The Journal of Physical Chemistry B · doi:10.1021/jp512499r · Cited by 50

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.

Masliah, E., Iwai, A., Mallory, M. E., Uéda, K., & Saitoh, T. (1996) · Europe PMC (PubMed Central) · Cited by 168

Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

Irizarry, M. C., Kim, T., McNamara, M. J., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205

The Non-Amyloid-β Component of Alzheimer’s Disease Plaque Amyloid: Comparative Analysis Suggests a Normal Function as a Synaptic Plasticizer

George, J. M., & Clayton, D. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_16 · Cited by 3

Properties of NACP/α-synuclein and its role in Alzheimer’s disease

Iwai, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00036-3 · Cited by 78

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease

Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51